Literature DB >> 201719

Interaction of thyroid-stimulating antibodies with the human thyrotrophin receptor.

B R Smith, G A Pyle, V B Petersen, R Hall.   

Abstract

Thyroid-stimulating antibodies (TSAb) were found to inhibit the binding of labelled thyrotrophin (TSH) to thyroid membranes in a dose-dependent manner and this effect was localized in the Fab part of the TSAb molecule. Analysis of the binding data suggested that TSAb and TSH bound to the same receptor site. Production of cyclic AMP by the thyroid membranes was stimulated by TSAb and TSAb-Fab with a similar time course to that observed with TSH. Kinetic studies indicated that the binding of TSAb to the thyroid membranes was not rate-limiting in the process of stimulation of cyclic AMP production.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 201719     DOI: 10.1677/joe.0.0750401

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  5 in total

Review 1.  The thyrotropin receptor and its role in Graves' disease.

Authors:  B Rees Smith; C R Rickards; E Davies Jones; Y Kajita; P R Buckland; F M Creagh; R D Howells; F Hashim; A B Parkes; V B Petersen
Journal:  J Endocrinol Invest       Date:  1985-04       Impact factor: 4.256

Review 2.  The thyrotrophin receptor.

Authors:  S W Manley; A Knight; D D Adams
Journal:  Springer Semin Immunopathol       Date:  1982

3.  Binding of solubilized human TSH-receptor protein by peripheral blood lymphocytes of patients with Graves' disease.

Authors:  B Wenzel; K W Wenzel; P Kotulla; H Schleusener
Journal:  J Endocrinol Invest       Date:  1981 Apr-Jun       Impact factor: 4.256

4.  Brief Report - Monoclonal Antibodies Illustrate the Difficulties in Measuring Blocking TSH Receptor Antibodies.

Authors:  Terry F Davies; Syed A Morshed; Mihaly Mezei; Rauf Latif
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-15       Impact factor: 6.055

5.  The aptamer BC 007 for treatment of dilated cardiomyopathy: evaluation in Doberman  Pinschers of efficacy and outcomes.

Authors:  Sabine Werner; Gerd Wallukat; Niels-Peter Becker; Katrin Wenzel; Johannes Müller; Ingolf Schimke; Gerhard Wess
Journal:  ESC Heart Fail       Date:  2020-03-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.